𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis

✍ Scribed by Susan M. Galbraith; Martin A. Lodge; N. Jane Taylor; Gordon J. S. Rustin; Søren Bentzen; J. James Stirling; Anwar R. Padhani


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
387 KB
Volume
15
Category
Article
ISSN
0952-3480

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The purpose of this study was to determine the reproducibility of dynamic contrast‐enhanced (DCE)‐MRI and compare quantitative kinetic parameters with semi‐quantitative methods, and whole region‐of‐interest (ROI) with pixel analysis. Twenty‐one patients with a range of tumour types underwent paired MRI examinations within a week, of which 16 pairs were evaluable. A proton density‐weighted image was obtained prior to a dynamic series of 30 T~1~‐weighted spoiled gradient echo images every 11.9 s with an intravenous bolus of gadopentetate dimeglumine given after the third baseline data point. Identical ROIs around the whole tumour and in skeletal muscle were drawn by the same observer on each pair of examinations and used for the reproducibility analysis. Semi‐quantitative parameters, gradient, enhancement and AUC (area under the curve) were derived from tissue enhancement curves. Quantitative parameters (K^trans^, k~ep~, v~e~) were obtained by the application of the Tofts' model. Analysis was performed on data averaged across the whole ROI and on the median value from individual pixels within the ROI. No parameter showed a significant change between examinations. For all parameters except K^trans^, the variability was not dependent on the parameter value, so the absolute values for the size of changes needed for significance should be used for future reference rather than percentages. The size of change needed for significance in a group of 16 in tumours for K^trans^, k~ep~ and v~e~ was −14 to +16%, ±0.20 ml/ml/min (15%) and ±1.9 ml/ml (6%), respectively (pixel analysis), and −16 to +19%, ±0.23 ml/ml/min (16%) and ±1.9 ml/ml (6%) (whole ROI analysis). For a single tumour, changes greater than −45 to +83%, ± 0.78 ml/ml/min (60%) and ± 7.6 ml/ml (24%), respectively, would be significant (pixel analysis). For gradient, enhancement and AUC the size of change needed for significance in tumours was ±0.24 (17%), ±0.05 (6%) and ±0.06 (8%), respectively for a group of 16 (pixel analysis), and ±0.96 (68%), ±0.20 (25%) and ±0.22 (32%) for individuals. In muscle, the size of change needed for significance in a group of 16 for K^trans^, k~ep~ and v~e~ was −30 to +44%, ±0.81 ml/ml/min (61%) and ±1.7 ml/ml (13%). For gradient, enhancement and AUC it was ±0.09 (20%), ±0.02 (8%) and ±0.03 (12%). v~e~, enhancement and AUC are highly reproducible DCE‐MRI parameters. K^trans^, k~ep~ and gradient have greater variability, with larger changes in individuals required to be statistically significant, but are nevertheless sufficiently reproducible to detect changes greater than 14–17% in a cohort of 16 patients. Pixel analyses slightly improve reproducibility estimates and retain information about spatial heterogeneity. Reproducibility studies are recommended when treatment effects are being monitored. Copyright © 2002 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


New hybrid technique for accurate and re
✍ Ka-Loh Li; Alan Jackson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

## Abstract The accuracy and precision of two major approaches for analyzing dynamic MRI data from the first passage of a Gd‐DTPA contrast bolus are examined, using a Monte Carlo simulation. Method 1 fits the contrast concentration curve of the first pass to a two‐compartment kinetic model to deter

Comparison of dynamic contrast-enhanced
✍ J. H. Naish; D. M. McGrath; L. J. Bains; K. Passera; C. Roberts; Y. Watson; S. C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Abstract Dynamic contrast‐enhanced MRI (DCE‐MRI) is frequently used to provide response biomarkers in clinical trials of novel cancer therapeutics but assessment of their physiological accuracy is difficult. DCE‐CT provides an independent probe of similar pharmacokinetic processes and may be mod

Method for the quantitative assessment o
✍ Karl Hittmair; Gregor Gomiscek; Karl Langenberger; Michael Recht; Herwig Imhof; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

## Abstract In previous papers relative signal intensity increase was used as a quantitative assessment parameter for contrast uptake in contrastenhanced MRI. However, relative signal intensity increase does not only reflect contrast uptake but depends also on tissue parameters (native __T__~1~ rel

Determining and optimizing the precision
✍ Brian M. Dale; John A. Jesberger; Jonathan S. Lewin; Claudia M. Hillenbrand; Jef 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

## Abstract ## Purpose To examine the sensitivity of quantitative dynamic contrast enhanced MRI (DCE‐MRI) perfusion maps to errors in the various source images and to determine optimal imaging parameters for reducing this sensitivity. ## Materials and Methods A detailed analysis of the precision